GSK345931A structure
|
Common Name | GSK345931A | ||
|---|---|---|---|---|
| CAS Number | 869499-38-7 | Molecular Weight | 403.83 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H19ClNNaO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GSK345931AGSK345931A is an EP1 receptor antagonist. GSK345931A shows measurable CNS penetration in the mouse and rat and potent analgesic efficacy in acute and sub-chronic models of inflammatory pain[1]. |
| Name | sodium,6-[2-[5-chloro-2-(2-methylpropoxy)phenyl]phenyl]pyridine-2-carboxylate |
|---|---|
| Synonym | More Synonyms |
| Description | GSK345931A is an EP1 receptor antagonist. GSK345931A shows measurable CNS penetration in the mouse and rat and potent analgesic efficacy in acute and sub-chronic models of inflammatory pain[1]. |
|---|---|
| Related Catalog | |
| Target |
EP1 |
| References |
| Molecular Formula | C22H19ClNNaO3 |
|---|---|
| Molecular Weight | 403.83 |
| Exact Mass | 403.09500 |
| PSA | 62.25000 |
| LogP | 4.46730 |
| InChIKey | HCPQFFJXXAUWBN-UHFFFAOYSA-M |
| SMILES | CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)[O-])n1.[Na+] |
| unii-u73bv4mml7 |